Feb 9 (Reuters) – Shield Therapeutics PLC: * SHIELD THERAPEUTICS – FDA GRANTS ADDITIONAL EXCLUSIVITY FOR ACCRUFER * SHIELD THERAPEUTICS : EXCLUSIVITY REMAINS IN PLACE UNTIL 19 DEC 2028 IN ADDITION TO ACCRUFER/FERACCRU PATENT COVERAGE VALID UNTIL MID-2030S Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
LONDON, July 3 (Reuters) - Pop superstar Madonna released her fifteenth studio album on Friday,…
With construction-led development at the core of its philosophy, Jashn Golf Estate challenges the traditional…
By Kurt Hall and Nathan Layne NEW YORK, July 3 (Reuters) - Taylor Swift and…
Mumbai (Maharashtra) [India], July 3: Mumbai witnessed a grand celebration on Monday, 29th of June…
Mumbai (Maharashtra) [India], July 3: The Insurance Institute of India (III) conducted a seminar on…
Hyderabad (Telangana) [India], July 3: Country Club to Set Up Base in Türkiye Following the…